Current Perspectives on Selective Dopamine D3 Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders

202231 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Current topics in behavioral neurosciences

Volume 60, pp. 157-201

Field-Weighted Citation Impact: 17.96